Expertise in
6
conditions

Pierre-francois F. Laterre

St Luc University Hospital, UCLouvain
Brussels, BRU, BE 
Expertise in
6
conditions
St Luc University Hospital, UCLouvain
Brussels, BRU, BE 

Overview

Pierre-francois Laterre practices practicing medicine in Brussels, Belgium.

Laterre is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Pneumonia, Sepsis, Lactic Acidosis, COVID-19, and Liver Transplant.

They are actively involved in clinical research, co-authoring 147 peer reviewed articles and participating in 5 clinical trials.

Locations

St Luc University Hospital, UCLouvain
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS
A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS
Enrollment Status: Completed
Publish Date: August 03, 2026
Intervention Type: Other
Study Phase: Phase 3
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Biological
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of KBSA301 in Severe Pneumonia (S. Aureus)
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of KBSA301 in Severe Pneumonia (S. Aureus)
Enrollment Status: Completed
Publish Date: April 24, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
View 4 Less Clinical Trials

146 Total Publications

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Journal: Critical care (London, England)
Published: June 22, 2026

Frequently Asked Questions about Pierre-francois F. Laterre

Is Pierre-francois F. Laterre a top-rated expert for Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre-francois F. Laterre is classified as an Distinguished expert for Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre-francois F. Laterre participate in research or clinical trials?

Yes. Pierre-francois F. Laterre has published 146 articles and abstracts on conditions like Pneumonia. You can view a list of Pierre-francois F. Laterre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Laterre's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile